Flow cytometry in the preclinical development of biopharmaceuticals

Toxicologic Pathology

Volumn 27, Issue 1, 1999, Pages 32-37

  Gossett, Kent A ^a   Narayanan, Padma K ^a   Williams, Donna M ^a   Gore, Elizabeth R ^a   Herzyk, Danuta J ^a   Hart, Timothy K ^a   Sellers, Teresa S ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Animal; Biopharmaceuticals; Drug development; Flow cytometry; Pharmacology; Toxicology

Indexed keywords

CD4 ANTIGEN; KELIXIMAB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY CD45R; OKT 4; OKT 8; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL CELL; ANTIGEN EXPRESSION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESEARCH; DRUG SAFETY; FLOW CYTOMETRY; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALIA; MUS MUSCULUS;

EID: 0033017796     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339902700107     Document Type: Conference Paper

References (8)

1. Anderson D, Chambers K, Hanna N, Leonard J, Reff M, Newman R, Baldoni J, Dunleavy D, Reddy M, Sweet R, and Truneh A (1997). A primatized Mab to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: In vitro and in vivo characterization of a Mab (IDEC-CE9.1) to human CD4. Clin. Immunol. Immunopathol. 84: 73-84.
2. Givan AL (1992). Flow Cytometry: First Principles. Wiley-Liss, New York.
3. Killeen N, Sawada S, and Littman DR (1993). Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J. 12: 1547-1553.
4. McCoy JP (1994). Basic principles in clinical flow cytometry. In: Flow Cytometry in Clinical Diagnosis, DF Keren et al (eds). American Society of Clinical Pathologists Press, Chicago, pp. 26-55.
5. Morel P, Vincent C, Cordier G, Panaye G, Carosella E, and Revillard JP (1990). Anti-CD4 monoclonal antibody administration in renal transplanted patients. Clin. Immunol. Immunopathol. 56: 311-322.
6. Shizuru JA, Gregory AK, Chao CT, and Fathman CG (1987). Islet allograft survival after a single course of treatment with antibody to L3T4. Science 237: 278-280.
7. Waldor MK, Sriram S, Hardy R, Herzenberg L, Lanier L, Lim M, and Steinman L (1985). Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 227: 415-417.
8. Weingand K, Brown G, Hall R, Davies D, Gossett K, Neptun D, Waner T, Matsuzawa T, Salemink P, Froelke W, Provost JP, Dal Negro G, Batchelor J, Nomura M, Groetsch H, Boink A, Kimball J, Woodman D, York M, Fabianson-Johnson E, Lupart M, and Melloni E (1996). Harmonization of animal clinical pathology testing in toxicity and safety studies. Fundam. Appl. Toxicol. 29:198-201.